Buy Addyi Online

Addyi is a flibanserin medication used for acquired, generalized hypoactive sexual desire disorder, or HSDD, in certain premenopausal women when low sexual desire causes distress. Addyi can be bought online through BorderFreeHealth, with current price details shown during ordering and the strength matched to the directions from your clinician. The commonly marketed presentation is the Addyi 100 mg tablet, sometimes called the pink pill, but it is not a same-day or as-needed sexual performance medicine.

Addyi Price and 100 mg Tablet Selection

Addyi price can vary by quantity, sourcing channel, and whether a person is paying cash. During ordering, choose the Addyi strength and quantity shown for the medication and make sure the directions match the treatment plan you were given. If you are comparing Addyi cost without insurance, look at the total cash price, the number of tablets, and any handling or delivery charges together rather than focusing on one figure alone.

The active ingredient is flibanserin. The usual marketed tablet strength described in labeling is 100 mg, taken as an ongoing bedtime medicine when appropriate. People searching for flibanserin 100 mg tablet or Addyi 100mg tablets are generally looking for the same active ingredient and strength, though brand naming and supply details can differ by market.

BorderFreeHealth works with licensed pharmacies for regulated medication supply and may review order details before the medication is released. U.S. customers using a Canada-based service should keep the name, strength, and directions consistent with the medication label they receive. US delivery from Canada may be part of the order experience, and prompt, express shipping can be selected at checkout when offered.

What Addyi Treats

Addyi treats acquired, generalized HSDD in certain premenopausal women. Acquired means the low desire developed after a period of previously typical desire. Generalized means it is not limited to one partner, situation, or type of sexual activity. The condition also involves personal distress, not simply a difference in desire between partners.

This distinction matters because low libido can have many causes. Relationship strain, depression, anxiety, pain with sex, vaginal dryness, medication side effects, alcohol use, sleep problems, and hormone-related conditions can all affect sexual interest. The hypoactive sexual desire disorder section gives broader condition context for people sorting through symptoms and treatment discussions.

Addyi is not indicated for men. It is also not generally used for low desire that is mainly due to painful intercourse, untreated vaginal dryness, a medical condition, a psychiatric condition, relationship problems, or the effects of another medicine or substance. Those situations may need a different evaluation before a desire-focused medicine makes sense.

How Flibanserin Works

Flibanserin is a non-hormonal medicine that acts in the central nervous system, meaning the brain and spinal cord. Its exact mechanism is not fully understood, but it affects neurotransmitters, including serotonin, dopamine, and norepinephrine. These chemical messengers are involved in mood, motivation, and sexual desire pathways.

Addyi is often compared online with female Viagra, but that comparison can be misleading. Sildenafil-type medicines mainly affect blood flow and are used shortly before sexual activity for erectile dysfunction. Flibanserin is taken on a daily schedule and is intended to affect desire over time, not to create an immediate physical response.

Because the medicine works in the brain, sedation, dizziness, and lightheadedness can occur. These effects are one reason the labeled dosing schedule uses bedtime administration. The medicine also requires careful review of alcohol use, liver history, and other medicines that may raise flibanserin levels or worsen impairment.

How Addyi Is Usually Taken

The labeled regimen for Addyi is 100 mg by mouth at bedtime. Bedtime use is important because taking flibanserin during waking hours can increase the risk of low blood pressure, fainting, accidental injury, and impaired alertness. Follow the directions on the medication label and do not change timing or frequency without guidance from a clinician.

If a dose is missed, labeling generally instructs patients to skip the missed dose and take the next dose at bedtime the following day. Doubling up can increase side effects without improving treatment response. If the medicine does not improve symptoms after an adequate trial, the official labeling describes stopping treatment after 8 weeks without improvement.

Quick tip: Use one consistent bedtime routine so doses are not accidentally taken during the day.

Taking Addyi responsibly also means keeping an updated medication list. Include sleep aids, anxiety medicines, pain medicines, antibiotics, antifungals, HIV medicines, supplements, and over-the-counter products. A complete list helps identify interaction risks before they lead to dizziness, fainting, or excessive sleepiness.

Strengths, Form, and Product Identity

Flibanserin is supplied as an oral tablet. The brand product is commonly recognized as a 100 mg tablet and is often called the pink pill because of its color. Always use the name, strength, and directions printed on the container you receive, since those details are the practical source for day-to-day use.

If the bottle, carton, or directions look different from what you expected, pause before taking the first tablet and ask for clarification from the pharmacy or your clinician. That simple step helps prevent mix-ups, especially if you take other daily medicines at bedtime.

Storage, Travel, and Handling

Store flibanserin tablets at controlled room temperature, away from excess heat and moisture. Bathrooms, parked vehicles, and windowsills can expose tablets to humidity or temperature swings. Keeping tablets in the original container also protects the label information and reduces the chance of confusing Addyi with another bedtime medicine.

For travel, carry Addyi in hand luggage with the pharmacy label visible. A photo of the label can help if you need the medication name, strength, or lot details while away from home. Time-zone changes can make bedtime dosing less straightforward, so plan your routine before departure rather than improvising after a long travel day.

Sexual health can change across life stages, and desire concerns may overlap with menopause symptoms, pelvic discomfort, or vaginal dryness. The women’s health category can help you browse related medication areas, while the women’s health articles section offers condition-focused reading for broader conversations with a clinician.

Side Effects, Warnings, and Monitoring

Common Addyi side effects include dizziness, sleepiness, nausea, fatigue, insomnia, and dry mouth. Some people feel lightheaded when standing quickly. These effects can be more concerning if the medicine is taken during waking hours, combined with alcohol, or used with other sedating medicines.

Serious risks include severe hypotension, meaning very low blood pressure, and syncope, meaning fainting. Fainting can cause falls or injury. Seek urgent medical help for fainting, severe dizziness, confusion, trouble staying awake, or symptoms that feel sudden or intense.

Alcohol is a major safety issue with flibanserin because it can increase the risk of low blood pressure and fainting. The Medication Guide includes specific alcohol-related instructions, and those instructions should be followed carefully. Do not guess about alcohol timing if your routine changes.

Moderate or strong CYP3A4 inhibitors can raise flibanserin levels. This interaction category includes some antifungals, antibiotics, HIV medicines, and other drugs. Grapefruit products are often discussed with medicines metabolized through CYP3A4, so ask whether they should be avoided with your medication plan.

Addyi should not be used in people with liver impairment according to labeling. Liver problems can increase drug exposure and raise the chance of serious side effects. Other central nervous system depressants, such as opioids, benzodiazepines, sleep medicines, and some muscle relaxants, may also add to sedation and impairment.

Why it matters: The most important Addyi safety risks involve fainting, low blood pressure, and impaired alertness.

When Addyi May Not Be the Right Fit

Addyi is not designed for every sexual health concern. If low desire is linked mainly to pain, vaginal dryness, relationship distress, untreated depression, a new medicine, or heavy alcohol use, those issues may need attention first. Treating the underlying contributor can be more appropriate than starting a brain-acting desire medication.

It also may not fit someone who cannot reliably take a bedtime medicine or who uses interacting medicines that cannot be changed. A person who works night shifts, uses sedatives, or has a history of fainting should discuss those details carefully. The practical question is not only whether Addyi treats HSDD, but whether it can be used safely in that person’s daily life.

For many people, the evaluation is personal and sensitive. It is reasonable to ask about expected benefits, side effects, alcohol restrictions, when to stop if it is not helping, and what other causes of low desire have been considered. Clear questions can make the decision feel less rushed and more grounded.

Related Options and Broader Women’s Health Context

Low desire can be multifactorial, so related choices depend on the main driver of symptoms. If the concern is diagnosed HSDD, Addyi is one medication that may be discussed. If the main problem is pain with sex, vaginal dryness, or menopausal genitourinary symptoms, local or hormone-related therapies may be more relevant than flibanserin.

People comparing therapy categories can use the women’s health medication category to see adjacent treatment areas. For condition education, HSDD information can help frame the difference between ongoing distressing low desire and occasional changes in libido.

Country-of-origin information may also matter to some customers using a cross-border medication service. Products associated with Canada country-of-origin details can be browsed separately when that helps with order planning. Use those details alongside the medication name, strength, and label directions rather than as a substitute for clinical suitability.

Authoritative Sources

For safety-critical decisions, use official labeling and clinician guidance. The FDA-approved label explains the indication, dosing schedule, alcohol warning, contraindications, interactions, and when treatment should be discontinued if symptoms do not improve.

For official label details, see Official Addyi prescribing information.

For patient-friendly drug information, see MedlinePlus flibanserin information.

This content is for informational purposes only and is not a substitute for professional medical advice.